{"CVE Code": "CVE-2023-40153", "Description": "The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.", "NVD Link": "https://nvd.nist.gov/vuln/detail/CVE-2023-40153", "Vulnerability Categories": "Cross site scripting (XSS)", "Affected Products": "\nDexma\u00bbDexgate\u00bbVersion:20130114cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:*Matching versions", "EPSS Score": "0.06% Probability of exploitation activity in the next 30 days\n~ 28 % Percentile, the proportion of vulnerabilities that are scored at or less", "EPSS History": "\n #  Date  Old EPSS Score  New EPSS Score  Delta (New - Old) \n 1  2024-10-25  0.05%  0.06%  +0.01 \n 2  2024-09-18  0.05%  0.05%  +0.00 \n 3  2023-10-26  0.04%  0.05%  +0.00 ", "CVSS Scores": "5.4", "CWE": [{"CWE_ID": "CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')", "CWE_link": "/cwe-details/79/Improper-Neutralization-of-Input-During-Web-Page-Generation-.html"}], "Reference": [{"ref_link": "https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02", "ref_desc": "DEXMA DexGate | CISAThird Party Advisory;US Government ResourceCVEs referencing this url", "ref_cve_link": "https://www.cvedetails.com/reference-url-info/QlYOocUUwIeu1d2Kba6kZc9ILfo.html"}]}